APA (7th ed.) Citation

A, N., N, K., S, M., M, H., A, K., K, T., . . . S, F. (2026). Real-world effectiveness and safety of adjuvant atezolizumab in pathological stage IIA-IIIB non-small cell lung cancer following curative surgery. Journal of thoracic disease, 18(3), 217. https://doi.org/10.21037/jtd-2025-1-2564

Chicago Style (17th ed.) Citation

A, Nakamura, et al. "Real-world Effectiveness and Safety of Adjuvant Atezolizumab in Pathological Stage IIA-IIIB Non-small Cell Lung Cancer Following Curative Surgery." Journal of Thoracic Disease 18, no. 3 (2026): 217. https://doi.org/10.21037/jtd-2025-1-2564.

MLA (9th ed.) Citation

A, Nakamura, et al. "Real-world Effectiveness and Safety of Adjuvant Atezolizumab in Pathological Stage IIA-IIIB Non-small Cell Lung Cancer Following Curative Surgery." Journal of Thoracic Disease, vol. 18, no. 3, 2026, p. 217, https://doi.org/10.21037/jtd-2025-1-2564.